1. Home
  2. BNGO vs CTXR Comparison

BNGO vs CTXR Comparison

Compare BNGO & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.58

Market Cap

24.3M

Sector

Industrials

ML Signal

HOLD

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.89

Market Cap

19.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNGO
CTXR
Founded
2003
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
19.8M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
BNGO
CTXR
Price
$1.58
$0.89
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$6.33
$6.00
AVG Volume (30 Days)
146.0K
1.6M
Earning Date
11-13-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$28,720,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$24.56
$147.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.45
$0.63
52 Week High
$15.60
$3.82

Technical Indicators

Market Signals
Indicator
BNGO
CTXR
Relative Strength Index (RSI) 48.46 42.93
Support Level $1.47 $0.76
Resistance Level $1.64 $0.99
Average True Range (ATR) 0.05 0.11
MACD 0.01 0.01
Stochastic Oscillator 72.06 48.73

Price Performance

Historical Comparison
BNGO
CTXR

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: